Hikma Pharmaceuticals · 1 day ago
Summer Internship - Pharmaceutical Manufacturing
Hikma Pharmaceuticals is seeking a motivated and high‑performing Summer Intern to join our Operations team at our Columbus, Ohio site. This internship offers meaningful, hands‑on experience within pharmaceutical manufacturing and packaging, allowing students to contribute to projects that support the safe and efficient delivery of products.
Health CareMedicalPharmaceutical
Responsibilities
Supporting projects focused on equipment downtime reduction, capacity optimization, and workflow efficiency
Assisting with supply chain and throughput assessments to identify opportunities for process improvement
Gathering and analyzing production data to develop visual management tools and performance reports
Contributing to development or updates of changeover maps, standard work, and 5S activities
Supporting capital project activities, including data verification, documentation, and coordination tasks
Performing verification of product standards and other inputs needed for accurate capacity planning
Qualification
Required
Undergraduate, Graduate, or Professional student in good academic standing
Completion of at least 12 credit hours within a related major or relevant coursework
Minimum cumulative GPA of 3.0 on a 4.0 scale
Must be at least 18 years of age
Legally authorized to work in the United States without restriction
Willingness to complete a background investigation (employment, criminal history, education verification)
Willingness to take a drug test and physical
Proficiency in Microsoft Office applications
Strong communication, analytical, mathematical, and problem‑solving skills
Effective planning and organizational abilities
Preferred
Incoming juniors or seniors with an interest in continuous improvement methodologies (Lean Manufacturing, Six Sigma, etc.)
Majors related to Operations, Industrial Engineering, Manufacturing, Supply Chain, or similar fields
Company
Hikma Pharmaceuticals
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products
Funding
Current Stage
Public CompanyTotal Funding
$250MKey Investors
International Finance Corporation
2025-07-15Post Ipo Debt· $250M
2005-11-04IPO
Recent News
London Evening Standard
2025-12-16
2025-12-15
MarketScreener
2025-12-15
Company data provided by crunchbase